InfuSystem Holdings, Inc.
AMEX:INFUMedical - Instruments & Supplies
+$0.35 today
- Market cap
- $293.89M
- Beta
- 1.42
- P/E (TTM)
- 23.2
- EPS (TTM)
- $0.39
Volume 0.16M
Average 0.16M
INFU Net Income
Bottom-line profit, the starting point for calculating cash from operations.
InfuSystem Holdings, Inc.AMEX: INFU
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income turns positive
Q1 FY2026 net income was $1.02M, compared with -$267K a year earlier. Trailing-twelve-month net income was $7.91M. Over 3 fiscal years it compounded at +616.7% a year.
Context
- Net income amounted to 4.6% of revenue in FY2025, up 2.9 pp from a year earlier.
- Net income increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of $10.4M (+56.9%) for the fiscal year ending Dec 2026, a slowdown from the +182.6% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $1.02M-50.0% QoQ
- Last fiscal yearDec 2025
- $6.63M+182.6% YoY
- LTMMar 2026
- $7.91M+148.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +480.9% | -14.9% | -495.8 pp |
| 1 year | +182.6% | +56.9% | -125.7 pp |
| 3-year CAGR | +616.7% | +28.2% | -588.5 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 6.63M USD
- Year-over-year change
- +182.6%
- 4-year CAGR
- +47.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.63M | +182.6% |
| FY2024 | 2024-12-31 | 2.35M | +168.9% |
| FY2023 | 2023-12-31 | 872K | +4744.4% |
| FY2022 | 2022-12-31 | 18K | -98.7% |
| FY2021 | 2021-12-31 | 1.42M | — |
Net Income vs competitors
How INFU compares with its peers on the latest reported figures
- INFU's LTM Mar 2026 net income of $7.91M is the 2nd largest of the 3 companies compared; the peer median is $13.91M.
- Its year-over-year change of +148.0% is the 2nd highest of 3, against a peer median of +62.2%.
- Net income amounts to 5.6% of revenue for INFU, versus a peer median of 3.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $30.09M | +181.4% | — | 1.4% | |
| LTM Mar 2026 | $7.91M | +148.0% | +616.7% | 5.6% | |
| LTM Mar 2026 | $2.28M | -57.0% | -32.7% | 5.3% | |
| Peer median (excluding INFU) | $13.91M | +62.2% | -32.7% | 3.3% | |
Competitors are the stored peer set for INFU. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 1.42M | 18K | 872K | 2.35M | 6.63M |
| Depreciation & Amortization | 14.63M | 13.36M | 12.51M | 12.5M | 13.29M |
| Deferred Income Tax | (153K) | 19K | 633K | 1.92M | 2.73M |
| Stock-Based Compensation | 6.4M | 3.83M | 4.07M | 4.46M | 4.36M |
| Change in Working Capital | (2.69M) | 385K | (5.56M) | 652K | (94K) |
| Accounts Receivables | 829K | (1.15M) | (2.36M) | (701K) | 263K |
| Inventory | (864K) | (882K) | (1.58M) | (126K) | 1.14M |
| Accounts Payables | (2.36M) | 2.94M | 2.42M | (676K) | (708K) |
| Other Working Capital | (294K) | (522K) | (4.03M) | 2.16M | (789K) |
| Other Non-Cash Items | (1.29M) | (90K) | (1.3M) | (1.42M) | (2.51M) |
| Operating Cash Flow | 18.32M | 17.52M | 11.22M | 20.46M | 24.41M |
| Capital Expenditures | (16.66M) | (15.08M) | (11.12M) | (17.83M) | (560K) |
| Acquisitions (Net) | (7.98M) | 3.6M | 4.38M | 4.59M | (1.41M) |
| Purchases of Investments | 0 | (14.09M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 10.5M | 0 | 0 | 0 |
| Other Investing Activities | 3.32M | 3.6M | 4.38M | (12.15M) | (4.82M) |
| Investing Cash Flow | (21.32M) | (11.48M) | (6.73M) | (13.24M) | (6.79M) |
| Debt Repayment | (5.47M) | (13K) | (3.95M) | (5.32M) | (4.32M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 335K |
| Common Stock Repurchased | (1.73M) | (6.65M) | (1.31M) | (2M) | (10.97M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 738K | 605K | 835K | 387K | 0 |
| Financing Cash Flow | (6.46M) | (6.06M) | (4.42M) | (6.92M) | (14.96M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (9.46M) | (21K) | 66K | 296K | 2.66M |
| Free Cash Flow | 1.66M | 2.44M | 106K | 2.63M | 23.85M |
InfuSystem Holdings, Inc.
AMEX:INFU
Intrinsic Alpha fair value
Locked
Current Price
$14.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.